BREAKING NEWS: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer (read more here).
Go here to learn more or to get a mailed copy.
Home » Archives for December 2016
Challenge Awards are multi-year team science projects that focus specifically on permanent solutions for lasting remissions that advanced prostate cancer patients urgently need. This is an area of urgent clinical...Read More